在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

LMO2 Recombinant Monoclonal Antibody

  • 中文名稱:
    LMO2重組抗體
  • 貨號:
    CSB-RA825959A0HU
  • 規(guī)格:
    ¥1320
  • 圖片:
    • Western Blot
      Positive WB detected in: U937 whole cell lysate, U87 whole cell lysate, PC3 whole cell lysate, MCF-7 whole cell lysate
      All lanes: LMO2 antibody at 1:2000
      Secondary
      Goat polyclonal to rabbit IgG at 1/50000 dilution
      Predicted band size: 19, 26, 6 kDa
      Observed band size: 20-25, 90-100 kDa
  • 其他:

產(chǎn)品詳情

  • 產(chǎn)品描述:
    CSB-RA825959A0HU LMO2重組單克隆抗體是經(jīng)ELISA和免疫印跡嚴(yán)格驗(yàn)證的高特異性科研試劑。該抗體靶向LIM結(jié)構(gòu)域轉(zhuǎn)錄因子LMO2,該蛋白在造血系統(tǒng)發(fā)育和T細(xì)胞白血病發(fā)生中起關(guān)鍵調(diào)控作用,其異常表達(dá)與多種惡性腫瘤的發(fā)生發(fā)展密切相關(guān)。本產(chǎn)品采用重組單克隆抗體技術(shù),在免疫印跡實(shí)驗(yàn)中展現(xiàn)出優(yōu)異的特異性,能準(zhǔn)確識別內(nèi)源性LMO2蛋白,推薦使用1:500-1:2000稀釋度可獲得清晰的目標(biāo)條帶,且不同批次間具有高度穩(wěn)定性。適用于探索LMO2在腫瘤發(fā)生、造血分化等領(lǐng)域的分子機(jī)制研究,可作為細(xì)胞模型或組織樣本中LMO2蛋白表達(dá)的可靠檢測工具,為癌癥生物學(xué)、發(fā)育生物學(xué)等基礎(chǔ)研究提供重要技術(shù)支持。本產(chǎn)品經(jīng)嚴(yán)格質(zhì)控確保實(shí)驗(yàn)可重復(fù)性,所有數(shù)據(jù)均來源于科研用途驗(yàn)證,不適用于其他領(lǐng)域。
  • Uniprot No.:
  • 基因名:
    LMO2
  • 別名:
    Rhombotin-2 (Cysteine-rich protein TTG-2) (LIM domain only protein 2) (LMO-2) (T-cell translocation protein 2), LMO2, RBTN2 RBTNL1 RHOM2 TTG2
  • 反應(yīng)種屬:
    Human
  • 免疫原:
    A synthesized peptide derived from human LMO2
  • 免疫原種屬:
    Homo sapiens (Human)
  • 標(biāo)記方式:
    Non-conjugated
  • 克隆類型:
    Monoclonal
  • 抗體亞型:
    Rabbit IgG
  • 純化方式:
    Affinity-chromatography
  • 克隆號:
    9H9
  • 濃度:
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液:
    Rabbit IgG in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol.
  • 產(chǎn)品提供形式:
    Liquid
  • 應(yīng)用范圍:
    ELISA, WB
  • 推薦稀釋比:
    Application Recommended Dilution
    WB 1:500-1:2000
  • Protocols:
  • 儲存條件:
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期:
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
  • 用途:
    For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評價

靶點(diǎn)詳情

  • 功能:
    Acts with TAL1/SCL to regulate red blood cell development. Also acts with LDB1 to maintain erythroid precursors in an immature state.
  • 基因功能參考文獻(xiàn):
    1. the data in this study revealed a novel crosstalk between LMO2 and the Wnt signaling pathway during tumorigenesis and suggested that LMO2 might be a tumor suppressor in certain solid tumors. PMID: 27779255
    2. LMO2 has a predominantly cytoplasmic location in breast cancer cells. LMO2 interaction with cofilin1 regulates actin cytoskeleton dynamics, promoting tumor cell invasion and metastasis. PMID: 27880729
    3. These data indicate that Lhx2 is capable of blocking proliferation of T-ALL-derived cells by both LMO2-dependent and -independent means. We propose Lhx2 as a new molecular tool for anti-T-ALL drug development. PMID: 29278703
    4. stromal LMO2 may be responsible for zonal characteristic of Prostate cancer PMID: 27028859
    5. The transcriptional factor LMO2 regulates endothelial proliferation and angiogenesis in vitro. PMID: 27792641
    6. This article demonstrates a novel and unexpected function of the LMO2 oncogenic transcription factor in controlling DNA replication that we unravelled via an unbiased proteome-wide screen for LMO2-interacting partners. PMID: 26764384
    7. Findings suggest that LMO2 loss may be a good predictor for the presence of MYC translocation in large B-cell lymphoma. PMID: 28288039
    8. FOXP3 binds LMO2 in vitro, resulting in decreased interaction between LMO2 and TAL1, providing a molecular mechanism for FOXP3-mediated transcriptional modulation in T-ALL. PMID: 26686090
    9. recurrent activating intronic mutations of LMO2, a prominent oncogene in T-cell acute lymphoblastic leukemia (T-ALL). Heterozygous mutations were identified in PF-382 and DU.528 T-ALL cell lines in addition to 3.7% of pediatric (6 of 160) and 5.5% of adult (9 of 163) T-ALL patient samples. PMID: 28270453
    10. Data indicate a novel functional mechanism of LMO2 in facilitating the delivery of actin monomers to the branched microfilament and increasing lamellipodia/filopodia formation in basal-type breast cancer cells. PMID: 28170369
    11. we demonstrate previously unrecognized mechanisms by which LMO2 alters human T-cell development in vivo; these mechanisms correlate with human T-ALL leukemogenesis. PMID: 27302866
    12. this study revealed a novel function of LMO2 involving in the regulatory hierarchy of UBA6-USE1-FAT10ylation pathway by targeting the E1 enzyme UBA6. PMID: 27569286
    13. LMO2 is a useful marker for immunophenotypic assessment of thymic neoplasms. PMID: 26796495
    14. LMO2 was associated with increased levels of cytosolic p27(Kip1) protein. PMID: 26383528
    15. that suppression of MIR223 expression, as compared with controls, is associated with lack of differentiation and adverse cytogenetic profile, but unrelated with LMO2 protein expression or overall survival. PMID: 25710580
    16. Alanine scanning mutagenesis of the LIM interaction domain of LDB1 revealed a discrete motif, R(320)LITR, required for LMO2 binding. PMID: 26598604
    17. LMO2 expression was elevated in GBM tissues and inversely correlated with prognosis of GBM patients. Taken together, our findings describe novel dual roles of LMO2 to induce tumorigenesis and angiogenesis. PMID: 25721045
    18. Diagnostic Utility of the Germinal Center-associated Markers GCET1, HGAL, and LMO2 in Hematolymphoid Neoplasms. PMID: 25203428
    19. Data show that the Lim domain only 2 (LMO2) regulatory element (element-25) region consists of transcription factor GATA2-binding myeloid ennhancer and RUNX protein-binding T-cell repressor. PMID: 26161748
    20. Cryptic chromosomal rearrangements in the LMO2 gene were associated with T-cell acute lymphoblastic leukemia. PMID: 25682596
    21. results suggest that E47 has diverse effects in T-ALL but that functional deficiency of E47 is not a universal feature of Lmo2-induced T-ALL. PMID: 25499232
    22. HHEX is a direct transcriptional target of LMO2 consistent with its concordant gene expression. PMID: 24465765
    23. LMO2 is expressed in a subset of acute myeloid leukaemia patients and is associated with normal karyotype, which is different from T lymphoblastic lymphoma/leukaemia, where specific translocation (11p13) mediates protein expression. PMID: 24330148
    24. GATA2 and Lmo2 cooperatively regulate VEGF-induced angiogenesis and lymphangiogenesis via NRP2. PMID: 23892628
    25. In t(8;21) leukemia cells, LMO2 functions as a component of the stable AML1-ETO-containing transcription factor complex (AETFC). The AETFC components cooperatively regulate gene expression and contribute to leukemogenesis. PMID: 23812588
    26. a regulatory hierarchy of HOX control of LMO2 in normal development PMID: 23708655
    27. Staining for LMO2 in addition to CD10 and BCL6 facilitates the detection of a germinal center phenotype in follicular lymphoma PMID: 23897248
    28. HGAL and LMO2 may be useful adjuncts in the identification of follicular lymphoma of the nongastric gastrointestinal tract. PMID: 22914613
    29. LMO2 expression is a special feature of germinal center diffuse large B cell lymphomas. PMID: 22776842
    30. Transcriptional regulators cooperate to establish or maintain primitive stem cell-like signatures in leukemic cells. PMID: 23327922
    31. The new anti-LMO2 antibody can be applied confidently to routine sections, contributing to the differential diagnosis of several lymphoma subtypes, subtyping of DLBCLs and potential development of innovative therapies. PMID: 22394247
    32. Germline genetic variation in LMO2 was associated with diffuse large B-cell lymphoma prognosis and provided slightly stronger predictive ability relative to LMO2 immunohistochemistry status. PMID: 22066713
    33. evidence that the H3K9-me1/2 demethylase KDM3B might play a role in leukemogenesis via activation of lmo2 through interdependent actions with the histone acetyltransferase complex containing CBP PMID: 22615488
    34. Overexpression of LMO2 in diffuse large B-cell (DLBCL) cell lines results in centrosome amplification. PMID: 22517897
    35. B-cell acute lymphoblastic leukemia cases expressed variable levels of LMO2 depending on immunophenotypical and cytogenetic features PMID: 21459790
    36. SStudies suggest that the expression of LMO2 protein in lymphoma tissue biopsies predicts survival in patients with RA who have developed DLBCL PMID: 21375434
    37. Data suggest that both HGAL and LMO2 are directly regulated by the transcription repressor PRDM1--overexpression of PRDM1 down-regulates HGAL and LMO2; PRDM1 directly binds to promoters of both HGAL and LMO2 and represses genetic transcription. PMID: 21722313
    38. The measurement of a single gene expressed by tumor cells (LMO2) and a single gene expressed by the immune microenvironment (TNFRSF9) powerfully predicts overall survival in patients with diffuse large B-cell lymphoma. PMID: 21670469
    39. LMO2 is sensitive and specific marker for detecting follicular lymphoma in nodal and extranodal sites PMID: 21502424
    40. both Lmo2 and Bcl-2 are required for the action of E2A-HLF in leukemogenesis PMID: 21072044
    41. first structural model of the DNA-binding complex containing LMO2, LDB1, SCL/TAL1, and GATA-1 PMID: 21076045
    42. Multiple-wavelength anomalous dispersion (MAD) data have been collected at the zinc X-ray absorption edge to a resolution of 2.8 A and the data were used to solve the structure of the LMO2:Ldb1-LIM-interaction domain complex. PMID: 21045296
    43. LMO2 probably promotes angiogenesis by up-regulation of bFGF expression and thereby consequently influences progression of infantile haemangiomas PMID: 20955387
    44. As LMO2 controls hematopoiesis, its dysregulation is leukemogenic PMID: 21059912
    45. Overexpression of either KLF1 or LMO2 partially rescued the defect in erythropoiesis caused by c-myb silencing, whereas only KLF1 was also able to repress the megakaryocyte differentiation enhanced in Myb-silenced CD34+ cells. PMID: 20686118
    46. ectopically expressed LMO2 impaired the function of DeltaEF1 in both transcriptional and protein levels and identified DeltaEF1 as a novel pathogenic target of LMO2 in T-cell leukemia. PMID: 20731704
    47. a self-sustaining triad of LMO2/ERG/FLI1 stabilizes the expression of important mediators of the leukaemic phenotype such as HHEX/PRH. PMID: 20676125
    48. We report that LMO2 protein is expressed in a significant proportion of B-ALL and AML and the staining of LMO2 protein does not predict survival in acute leukemia. PMID: 20557670
    49. E2A-HLF promotes cell survival of t(17;19)- acute lymphoblastic leukemia cells by aberrantly up-regulating LMO2 expression PMID: 20519628
    50. Our results show that HGAL and LMO2 are sensitive markers for follicular lymphoma diagnosis. PMID: 20697248

    顯示更多

    收起更多

  • 相關(guān)疾病:
    A chromosomal aberration involving LMO2 may be a cause of a form of T-cell acute lymphoblastic leukemia (T-ALL). Translocation t(11,14)(p13;q11) with TCRD.
  • 亞細(xì)胞定位:
    Nucleus.
  • 數(shù)據(jù)庫鏈接:

    HGNC: 6642

    OMIM: 180385

    KEGG: hsa:4005

    STRING: 9606.ENSP00000257818

    UniGene: Hs.34560



主站蜘蛛池模板: 又色又爽又黄的视频软件app| 日本高清www无色夜在线视频| 狠狠做五月深爱婷婷| 麻花传媒在线观看免费| 欧美精品无码一区二区三区| av片在线观看免费| 七七久久成人影院网站| 双乳被一左一右吃着动态图| 国产在线视频一区二区三区98 | 免费观看性行为视频的网站| 饥渴丰满少妇大力进入| 和黑人邻居中文字幕在线| 黑人粗硬进入过程视频| 人妻无码中文字幕| 香蕉久久国产超碰青草| 国产网红女主播精品视频| 蜜桃视频一区二区在线观看| 色欲色香天天天综合无码| 97国产在线看片免费人成视频| 久久久成人毛片无码| 妺妺窝人体色www聚色窝仙踪| 国产精品国语对白露脸在线播放| 99精品全国免费观看视频| 亚洲自偷自拍熟女另类| 欧美成人一区二区三区| 国产区又黄又硬高潮的视频| 狠狠综合久久久久尤物| 亚洲人成网网址在线看| 无码人妻精品一区二区蜜桃网站| 人妻少妇精品专区性色av| 亚洲国产成人精品无码区二本 | 色婷婷久久综合中文久久一本| 美女被啪到深处抽搐视频| 日本高清一区二区三| 精品人妻伦一二三区久久| 亚洲精品欧美综合一区二区| 日韩中文亚洲欧美视频二| 欧美性xxxxx极品娇小| 亚洲aⅴ在线无码天堂777| 国产精品日本亚洲欧美| 国产精品高清一区二区三区|